178 related articles for article (PubMed ID: 23179393)
1. Mevalonate pathway is a therapeutic target in esophageal squamous cell carcinoma.
Shi J; Zhu J; Zhao H; Zhong C; Xu Z; Yao F
Tumour Biol; 2013 Feb; 34(1):429-35. PubMed ID: 23179393
[TBL] [Abstract][Full Text] [Related]
2. HMGCR is necessary for the tumorigenecity of esophageal squamous cell carcinoma and is regulated by Myc.
Zhong C; Fan L; Yao F; Shi J; Fang W; Zhao H
Tumour Biol; 2014 May; 35(5):4123-9. PubMed ID: 24390662
[TBL] [Abstract][Full Text] [Related]
3. Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas.
Dimitroulakos J; Marhin WH; Tokunaga J; Irish J; Gullane P; Penn LZ; Kamel-Reid S
Neoplasia; 2002; 4(4):337-46. PubMed ID: 12082550
[TBL] [Abstract][Full Text] [Related]
4. Deoxypodophyllotoxin, a Lignan from
Kwak AW; Lee MH; Yoon G; Cho SS; Choi JS; Chae JI; Shim JH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961992
[TBL] [Abstract][Full Text] [Related]
5. TRAF6 promoted the tumorigenicity of esophageal squamous cell carcinoma.
Yao F; Han Q; Zhong C; Zhao H
Tumour Biol; 2013 Oct; 34(5):3201-7. PubMed ID: 23794111
[TBL] [Abstract][Full Text] [Related]
6. The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest.
Cheng YW; Liao LD; Yang Q; Chen Y; Nie PJ; Zhang XJ; Xie JJ; Shan BE; Zhao LM; Xu LY; Li EM
Cell Biochem Funct; 2018 Dec; 36(8):398-407. PubMed ID: 30484863
[TBL] [Abstract][Full Text] [Related]
7. Elevated serine protease HtrA1 inhibits cell proliferation, reduces invasion, and induces apoptosis in esophageal squamous cell carcinoma by blocking the nuclear factor-κB signaling pathway.
Xia J; Wang F; Wang L; Fan Q
Tumour Biol; 2013 Feb; 34(1):317-28. PubMed ID: 23079781
[TBL] [Abstract][Full Text] [Related]
8. Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3.
Cao Y; Yin X; Jia Y; Liu B; Wu S; Shang M
Int J Mol Med; 2018 Sep; 42(3):1569-1576. PubMed ID: 29901084
[TBL] [Abstract][Full Text] [Related]
9. LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma.
Yao F; Zhao T; Zhong C; Zhu J; Zhao H
Tumour Biol; 2013 Feb; 34(1):25-31. PubMed ID: 22961700
[TBL] [Abstract][Full Text] [Related]
10. Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells.
Mao L; Deng G; Li M; Lu SH; Jiang W; Yu X
Eur J Med Res; 2024 May; 29(1):293. PubMed ID: 38773551
[TBL] [Abstract][Full Text] [Related]
11. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo.
Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH
Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428
[TBL] [Abstract][Full Text] [Related]
12. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
[TBL] [Abstract][Full Text] [Related]
13. [Effect of bufalin on proliferation and apoptosis through ERK/RSK2 pathway in human esophageal carcinoma cell line xenografts in nude mice].
Yue M; Liu XJ; Ding Y; Wang XL; Yang HC; Liu YP
Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):325-32. PubMed ID: 27188603
[TBL] [Abstract][Full Text] [Related]
14. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
15. Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo.
Xie X; Zu X; Liu F; Wang T; Wang X; Chen H; Liu K; Wang P; Liu F; Zheng Y; Bode AM; Dong Z; Kim DJ
Mol Carcinog; 2019 Jul; 58(7):1248-1259. PubMed ID: 31100197
[TBL] [Abstract][Full Text] [Related]
16. [Chidamide inhibits proliferation and promotes apoptosis of esophageal squamous cell carcinoma cells by inhibiting the PI3K/Akt and ERK1/2 pathways and increasing DNA damage].
Gao M; Zhao B; Yang W; Tang J; Liu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Nov; 43(11):1926-1934. PubMed ID: 38081611
[TBL] [Abstract][Full Text] [Related]
17. Isoliquiritigenin Suppressed Esophageal Squamous Carcinoma Growth by Blocking EGFR Activation and Inducing Cell Cycle Arrest.
Ye L; Zhang J; Zhang Y; Gu B; Zhu H; Mao X
Biomed Res Int; 2020; 2020():9259852. PubMed ID: 32190688
[TBL] [Abstract][Full Text] [Related]
18. siRNA blocking the RAS signalling pathway and inhibits the growth of oesophageal squamous cell carcinoma in nude mice.
Wang X; Zheng Y; Fan Q; Zhang X; Shi Y
Cell Biochem Funct; 2014 Dec; 32(8):625-9. PubMed ID: 25430959
[TBL] [Abstract][Full Text] [Related]
19. Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo.
Cai X; Hu X; Tan X; Cheng W; Wang Q; Chen X; Guan Y; Chen C; Jing X
PLoS One; 2015; 10(7):e0133349. PubMed ID: 26196392
[TBL] [Abstract][Full Text] [Related]
20. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]